Physician profile
Douglas E Drachman
NPI 1245211176
$132,349.11
in general payments reported to CMS, 2019-2025
14 companies · $4,849 in 2025
The $4,849 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $41K · 2021: $19K · 2022: $25K · 2023: $5,012 · 2024: $618 · 2025: $4,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,365 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Food and Beverage: $1,314 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,365.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Food and Beverage | $1,314.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $95,257.99 | 2019-2023 | Diamondback Coronary |
| Abbott Laboratories | $20,541.76 | 2019-2025 | Diamondback Coronary, Dragonfly Opstar, Coroflow |
| Pfizer INC. | $5,635.00 | 2020-2023 | |
| Boston Scientific Corporation | $4,590.35 | 2019-2020 | |
| Shockwave Medical, INC | $3,228.68 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,347.78 | 2025 | |
| Cardinal Health 200 LLC | $1,100.00 | 2021 | |
| Penumbra, INC. | $159.07 | 2024 | Indigo System |
| Chiesi USA, INC. | $133.30 | 2025 | Kengreal |
| Cordis US Corp. | $122.84 | 2024 | Selution Slrpta |
| Edwards Lifesciences Corporation | $107.10 | 2024 | |
| Spectrawave, INC | $78.41 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Medtronic, INC. | $46.83 | 2023 | Onyx Frontier |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Drachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.